Ionis Pharmaceuticals Inc. Common Stock vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while State Street Real Estate Select Sector SPDR ETF trades at $41.83 (market cap $7.83B). The key difference: Ionis Pharmaceuticals Inc. Common Stock and State Street Real Estate Select Sector SPDR ETF are close in size by market cap, and State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and State Street Real Estate Select Sector SPDR ETF for 77 Days on average.
| IONS | XLRE | |
|---|---|---|
Market Cap | $7.04B | $7.83B |
Volume | 2,977,440 | 5,853,296 |
Sector | Health | Sector/Thematic |
52-Week High | $86.50 | $46.01 |
52-Week Low | $42.38 | $40.01 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $6.60B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLRE, the State Street Real Estate Select Sector SPDR ETF, trades at $41.83, down 0.21% on the day. The technical outlook is mixed, with a bullish overall signal but bearish moving averages. Key financial ratios are not available in the provided data. Recent news highlights the fund's low expense ratio of 0.08% and its focus on 30 U.S. large-cap real estate holdings, positioning it as a cost-effective domestic real estate exposure tool.
The outlook for XLRE is influenced by competing factors: its low-cost structure is a strength, but the sector faces headwinds from rising bond yields and potential interest rate volatility. Investment opportunity lies in its role as a pure-play U.S. real estate ETF, while risks include macroeconomic sensitivity and competition from more diversified or thematic real estate funds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →